The team says its work offers a promising platform for the development of advanced drug delivery systems and other biomedical ...
Targeting a brain enzyme called ABHD6 that degrades a key endocannabinoid molecule known as 2-AG could help fight obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback